CGB 0.00% 2.1¢ cann global limited

Will we all be rich tomorrow?, page-9

  1. 159 Posts.
    lightbulb Created with Sketch. 32
    The challenge as I see it, is that CGB doesn't sell much and doesn't seem to have any products (drugs) in development phase (at least).

    Whereas, many medicinal marijuana companies have products in clinical trials and many with drugs hitting the ground.

    As a long term holder, I got drawn into the conversation about the 'big stash of seeds' we apparently had and the trials in Israel or collaboration with Canntab in Canada... where is all that? Where has it gone? etc etc

    My point, these guys will talk the next thing up like a 3rd hand car with a shiny paint job... get excited cautiously.

    Sadly they don't seem to under what makes money - sales of great products.
 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.